Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Clinical trial NCT07394309 · COMPLETED
Trial details
- NCT number
- NCT07394309
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2026-05-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.